Cargando…
Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: a retrospective cohort study
BACKGROUND: Some patients with systemic autoimmune rheumatic disease and immunosuppression might still be at risk of severe COVID-19. The effect of outpatient SARS-CoV-2 treatments on COVID-19 outcomes among patients with systemic autoimmune rheumatic disease is unclear. We aimed to evaluate tempora...
Autores principales: | Qian, Grace, Wang, Xiaosong, Patel, Naomi J, Kawano, Yumeko, Fu, Xiaoqing, Cook, Claire E, Vanni, Kathleen M M, Kowalski, Emily N, Banasiak, Emily P, Bade, Katarina J, Srivatsan, Shruthi, Williams, Zachary K, Todd, Derrick J, Weinblatt, Michael E, Wallace, Zachary S, Sparks, Jeffrey A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940330/ https://www.ncbi.nlm.nih.gov/pubmed/36844970 http://dx.doi.org/10.1016/S2665-9913(23)00006-1 |
Ejemplares similares
-
Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: A retrospective cohort study
por: Qian, Grace, et al.
Publicado: (2022) -
Factors associated with COVID-19 breakthrough infection among vaccinated patients with rheumatic diseases: A cohort study
por: Patel, Naomi J., et al.
Publicado: (2023) -
Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: From the first wave to Omicron
por: Kawano, Yumeko, et al.
Publicado: (2022) -
Immunomodulators and risk for breakthrough infection after third COVID-19 mRNA vaccine among patients with rheumatoid arthritis: A cohort study
por: Schiff, Abigail E., et al.
Publicado: (2023) -
404. Impact of cross-coronavirus humoral immunity in post-acute sequelae of COVID-19 in systemic autoimmune rheumatic diseases patients
por: Herman, Jonathan, et al.
Publicado: (2023)